# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
New Corporate Brand to be Unveiled at AASLD Liver Meeting® 2023 with Interim Data
Alliance Global Partners analyst James Molloy initiates coverage on Vaccitech (NASDAQ:VACC) with a Buy rating and announces ...